As of April 16, 2025, OmniAb (OABI) has a market cap of $0.23 billion USD. According to our data, OmniAb is ranked No.6828 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.23 B |
-46.12%
|
Dec 31, 2024 | $0.43 B |
-42.63%
|
Dec 29, 2023 | $0.75 B |
71.39%
|
Dec 30, 2022 | $0.44 B |
-64.00%
|
Dec 31, 2021 | $1.21 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
![]() USA
|
![]() Ionis Pharmaceuticals
IONS
|
$4.51 B |
0.000 M
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
![]() USA
|
![]() Biogen
BIIB
|
$17.12 B |
0.000 M
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Moderna
MRNA
|
$10.14 B |
-0.001 M
|
![]() USA
|
![]() BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
![]() USA
|
Market Cap | = | OABI Stock Price | * | OABI Shares Outstanding |
= | $1.89 | * | 0.12 B | |
= | $0.23 B |